Pierre Massion
Faculty Member
Last active: 1/11/2018

  1. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer. Ocak S, Friedman DB, Chen H, Ausborn JA, Hassanein M, Detry B, Weynand B, Aboubakar F, Pilette C, Sibille Y, Massion PP (2014) J Thorac Oncol 9(3): 324-36
    › Primary publication · 24518087 (PubMed) · PMC4028683 (PubMed Central)
  2. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Braun NA, Celada LJ, Herazo-Maya JD, Abraham S, Shaginurova G, Sevin CM, Grutters J, Culver DA, Dworski R, Sheller J, Massion PP, Polosukhin VV, Johnson JE, Kaminski N, Wilkes DS, Oswald-Richter KA, Drake WP (2014) Am J Respir Crit Care Med 190(5): 560-71
    › Primary publication · 25073001 (PubMed) · PMC4214083 (PubMed Central)
  3. Biomarkers to the rescue in a lung nodule epidemic. Massion PP (2014) J Clin Oncol 32(8): 725-6
    › Primary publication · 24516023 (PubMed)
  4. Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer. Harris FT, Rahman SM, Hassanein M, Qian J, Hoeksema MD, Chen H, Eisenberg R, Chaurand P, Caprioli RM, Shiota M, Massion PP (2014) Cancer Prev Res (Phila) 7(7): 748-57
    › Primary publication · 24819876 (PubMed) · PMC4090029 (PubMed Central)
  5. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. Deppen SA, Blume JD, Kensinger CD, Morgan AM, Aldrich MC, Massion PP, Walker RC, McPheeters ML, Putnam JB, Grogan EL (2014) JAMA 312(12): 1227-36
    › Primary publication · 25247519 (PubMed) · PMC4315183 (PubMed Central)
  6. Tumour angiogenesis regulation by the miR-200 family. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK (2013) Nat Commun : 2427
    › Primary publication · 24018975 (PubMed) · PMC3904438 (PubMed Central)
  7. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Hassanein M, Hoeksema MD, Shiota M, Qian J, Harris BK, Chen H, Clark JE, Alborn WE, Eisenberg R, Massion PP (2013) Clin Cancer Res 19(3): 560-70
    › Primary publication · 23213057 (PubMed) · PMC3697078 (PubMed Central)
  8. Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells. Ardestani S, Li B, Deskins DL, Wu H, Massion PP, Young PP (2013) Cancer Res 73(13): 3938-50
    › Primary publication · 23704210 (PubMed) · PMC3702680 (PubMed Central)
  9. Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. Ajona D, Pajares MJ, Corrales L, Perez-Gracia JL, Agorreta J, Lozano MD, Torre W, Massion PP, de-Torres JP, Jantus-Lewintre E, Camps C, Zulueta JJ, Montuenga LM, Pio R (2013) J Natl Cancer Inst 105(18): 1385-93
    › Primary publication · 23940286 (PubMed) · PMC3776260 (PubMed Central)
  10. Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung. Wang J, Qian J, Hoeksema MD, Zou Y, Espinosa AV, Rahman SM, Zhang B, Massion PP (2013) Clin Cancer Res 19(20): 5580-90
    › Primary publication · 23908357 (PubMed) · PMC3807802 (PubMed Central)